JAZZ - Jazz Pharmaceuticals beats by $0.51 beats on revenue May, 07 2019 04:07 PM Jazz Pharmaceuticals plc Jazz Pharmaceuticals (NASDAQ:JAZZ): Q1 Non-GAAP EPS of $3.67 beats by $0.51; GAAP EPS of $1.47 misses by $0.12.Revenue of $508.2M (+14.3% Y/Y) beats by $41.65M.Press ReleaseMore news on: Jazz Pharmaceuticals plc, Earnings news and commentary, Healthcare stocks news,